NO20005250D0 - Kontrastmiddel - Google Patents

Kontrastmiddel

Info

Publication number
NO20005250D0
NO20005250D0 NO20005250A NO20005250A NO20005250D0 NO 20005250 D0 NO20005250 D0 NO 20005250D0 NO 20005250 A NO20005250 A NO 20005250A NO 20005250 A NO20005250 A NO 20005250A NO 20005250 D0 NO20005250 D0 NO 20005250D0
Authority
NO
Norway
Prior art keywords
dispersed
gas
preparations
perfusion
material present
Prior art date
Application number
NO20005250A
Other languages
English (en)
Other versions
NO20005250L (no
Inventor
Morten Eriksen
Helge Tolleshaug
Roald Skurtveit
Alan Cuthbertson
Jonny Istensen
Sigmund Frigstad
Pol Rongved
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO20005250D0 publication Critical patent/NO20005250D0/no
Publication of NO20005250L publication Critical patent/NO20005250L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Light Receiving Elements (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO20005250A 1998-04-22 2000-10-19 Kontrastmiddel NO20005250L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808599.6A GB9808599D0 (en) 1998-04-22 1998-04-22 Improvements in or realting to contrast agents
PCT/GB1999/001221 WO1999053963A1 (en) 1998-04-22 1999-04-22 Improvements in or relating to contrast agents

Publications (2)

Publication Number Publication Date
NO20005250D0 true NO20005250D0 (no) 2000-10-19
NO20005250L NO20005250L (no) 2000-12-18

Family

ID=10830802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005250A NO20005250L (no) 1998-04-22 2000-10-19 Kontrastmiddel

Country Status (17)

Country Link
US (1) US20040146462A1 (no)
EP (1) EP1073473B1 (no)
JP (1) JP2002512206A (no)
KR (1) KR20010042915A (no)
CN (1) CN1306442A (no)
AT (1) ATE375806T1 (no)
AU (1) AU3617299A (no)
BR (1) BR9909822A (no)
CA (1) CA2329175A1 (no)
DE (1) DE69937341D1 (no)
GB (1) GB9808599D0 (no)
HU (1) HUP0102878A3 (no)
IL (1) IL139147A0 (no)
NO (1) NO20005250L (no)
PL (1) PL343464A1 (no)
WO (1) WO1999053963A1 (no)
ZA (1) ZA200005789B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804162A (en) * 1995-06-07 1998-09-08 Alliance Pharmaceutical Corp. Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
DE10119522A1 (de) * 2001-04-20 2002-12-05 Innovacell Biotechnologie Gmbh Herstellung und Anwendung einer Suspensionszusammensetzung mit einem Ultraschall-Kontrastmittel
KR20050072496A (ko) 2002-11-29 2005-07-11 아머샴 헬스 에이에스 초음파 촬영 방법
US9364569B2 (en) 2003-02-04 2016-06-14 Bracco Suisse S.A. Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
AU2004308757B2 (en) * 2003-12-22 2010-06-17 Bracco Suisse S.A. Assembly of gas-filled microvesicle with active component for contrast imaging
JP5513708B2 (ja) * 2003-12-22 2014-06-04 ブラッコ・シュイス・ソシエテ・アノニム 造影イメージング用の気体封入マイクロベシクル・アセンブリー
US9248204B2 (en) 2004-08-18 2016-02-02 Bracco Suisse S.A. Gas-filled microvesicles composition for contrast imaging
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CN100453050C (zh) * 2005-09-21 2009-01-21 北京市肿瘤防治研究所 提高超声造影图像分辨力的方法和超声造影成像仪
US20080255266A1 (en) * 2007-04-10 2008-10-16 Gc Corporation Dental paste composition having x-ray imaging property
JP4279328B2 (ja) * 2007-05-07 2009-06-17 株式会社日立製作所 超音波撮像システム
US20110158909A1 (en) * 2008-02-01 2011-06-30 Trustees Of Boston University Cationic Contrast Agents and Methods of Use Thereof
JP5751708B2 (ja) * 2008-05-02 2015-07-22 セルセンス， インコーポレイテッド 核磁気共鳴技法および他の用途のためのエマルジョンを生成するための組成物ならびに方法
EP2470287A4 (en) 2009-08-28 2015-01-21 Univ Columbia SYSTEMS, METHODS AND DEVICES FOR PRODUCING GAS-FILLED MICROBUBBLES
DE102011005444A1 (de) * 2011-03-11 2012-09-13 Innora Gmbh Festes, negatives Röntgenkontrastmittel zur Darstellung des Gastrointestinaltraktes
SI3049117T1 (sl) 2013-09-27 2022-11-30 Exact Therapeutics As Dostava zdravil, posredovana z ultrazvokom
JOP20200052A1 (ar) * 2013-12-19 2017-06-16 Bayer Pharma AG بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c
US10905401B2 (en) * 2017-07-09 2021-02-02 The Board Of Trustees Of The Leland Stanford Junior University Ultrasound imaging with spectral compounding for speckle reduction
EP3678712A4 (en) * 2017-09-07 2021-06-02 Imbiotechnologies Ltd. EMBOLIC AGENTS SENSITIVE TO SOUND
CN108586300B (zh) * 2018-03-28 2020-03-17 成都福柯斯医药技术有限公司 一种s-碘化丁酰硫代胆碱的合成方法
CN114760989A (zh) 2019-10-25 2022-07-15 精准医疗股份有限公司 胰腺癌的治疗
GB2595513B (en) 2020-05-29 2023-03-29 Act Therapeutics Ltd Treatment of infections
US11801058B2 (en) * 2021-03-04 2023-10-31 Accumedical Beijing Ltd. Liquid embolic compositions
GB2605422A (en) 2021-03-31 2022-10-05 Act Therapeutics Ltd Treatment of the central nervous system
GB2605996A (en) 2021-04-21 2022-10-26 Act Therapeutics Ltd Enhancement of treatment with immunotherapeutic agents
EP4261786A1 (en) * 2022-03-28 2023-10-18 Tata Consultancy Services Limited Methods and system for low dose x ray computed tomography perfusion imaging

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5776429A (en) * 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5228446A (en) * 1989-12-22 1993-07-20 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
ES2231775T5 (es) * 1993-07-30 2011-02-02 Imcor Pharmaceutical Co. Composición de microburbujas estabilizadas para ecografía.
NO940711D0 (no) * 1994-03-01 1994-03-01 Nycomed Imaging As Preparation of gas-filled microcapsules and contrasts agents for diagnostic imaging
US5846517A (en) * 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
NZ335265A (en) * 1996-10-21 2000-07-28 Nycomed Imaging As Gas containing contrast agents that may be co-administered with vasodilator drugs to enhance differences in return signal intensity from normal and hypoperfused myocardial tissue contrast agents
ES2206689T3 (es) * 1996-10-28 2004-05-16 Amersham Health As Agentes de contraste.
EP0991427A2 (en) * 1996-10-28 2000-04-12 Marsden, John Christopher Improvements in or relating to diagnostic/therapeutic agents
WO1998018498A2 (en) * 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents

Also Published As

Publication number Publication date
AU3617299A (en) 1999-11-08
WO1999053963A1 (en) 1999-10-28
EP1073473B1 (en) 2007-10-17
CA2329175A1 (en) 1999-10-28
KR20010042915A (ko) 2001-05-25
JP2002512206A (ja) 2002-04-23
ATE375806T1 (de) 2007-11-15
ZA200005789B (en) 2001-07-30
HUP0102878A2 (hu) 2002-03-28
CN1306442A (zh) 2001-08-01
NO20005250L (no) 2000-12-18
BR9909822A (pt) 2000-12-19
PL343464A1 (en) 2001-08-13
US20040146462A1 (en) 2004-07-29
HUP0102878A3 (en) 2002-12-28
DE69937341D1 (de) 2007-11-29
IL139147A0 (en) 2001-11-25
EP1073473A1 (en) 2001-02-07
GB9808599D0 (en) 1998-06-24

Similar Documents

Publication Publication Date Title
NO20005250D0 (no) Kontrastmiddel
WO1998017324A3 (en) Improvements in or relating to contrast agents
EE03235B1 (et) Emulsioonvorm, selle valmistamise protsess ja kasutamine
KR950031069A (ko) 골손실의 억제 및 혈청 콜레스테롤의 강하 방법
DE69105106D1 (de) Im wasser schnell suspendierbare pharmazeutische zusammensetzung.
BR9610089A (pt) Microemulsão não tóxica de óleo em água ou bicontínua processo para sua preparação e uso da mesma
ECSP045496A (es) "preparaciones acidas de insulina con estabilidad mejorada"
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
RU94033520A (ru) Впрыскиваемый лецитиновый гель
BRPI0414128A (pt) sistema e método para aumento de mamas
EA200400242A1 (ru) Фармацевтические композиции, содержащие бета-лапахон или его производные или аналоги, и способы их применения
RU99124771A (ru) Применение альфа-метил-п-тирозина для ингибирования продуцирования меланина в меланоцитах радужной оболочки
CA2383600A1 (en) Method for determining viability of a myocardial segment
HRP20120165T1 (hr) Novi pripravci na bazi taksoida
US20040230122A1 (en) Ultrasound imaging
SE9402880D0 (sv) New peptide derivatives
Sugiyama et al. Histamine-release induced by 7S nervegrowth factor of mouse submandibular salivary glands
JP2001515053A (ja) 造影剤におけるまたは造影剤に関する改良
GB9808582D0 (en) Improvements in or relating to contrast agents
Møller et al. Neurohumoral fluid regulation in chronic liver disease
EA200101106A1 (ru) Фармацевтический комплекс
Flynn et al. Sarafotoxin S6c elicits a non-ETA or non-ETB-mediated pressor response in the pithed rat
Suzuki et al. PERIARTERITIS NODOSA IN SPONTANEOUSLY HYPERTENSIVE RATS:–Immunohistological Study and Permeability Test–
KR900017599A (ko) 종양 치료용 약학 조성물
Evans et al. Effects of chronic delta-9-THC treatment on cardiac beta-adrenoceptors in rats

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application